tiprankstipranks
Greenwich Lifesciences, Inc. (GLSI)
NASDAQ:GLSI
US Market
GLSI
Greenwich LifeSciences
RESEARCH TOOLSreports
Want to see GLSI full AI Analyst Report?

Greenwich LifeSciences (GLSI) Income Statement

444 Followers

Greenwich LifeSciences Income Statement

Last quarter (Q3 2025), Greenwich LifeSciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Greenwich LifeSciences's net income was $-4.15M. See Greenwich LifeSciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -3.61K$ -3.61K$ -3.61K$ -3.61K$ -3.61K
Operating Expenses
$ 16.01M$ 9.33M$ 8.04M$ 4.60M$ 1.86M
Depreciation and Amortization
$ 3.61K$ 3.61K$ 3.61K$ 3.61K$ 3.61K
EBITDA
$ -15.79M$ -9.32M$ -8.04M$ -4.59M$ -1.86M
Operating Income
$ -16.01M$ -9.33M$ -8.04M$ -4.60M$ -1.86M
Other Income/Expenses
$ 223.01K$ 436.06K$ 215.02K$ 27.37K$ 832.00
Pretax Income
$ -15.79M$ -8.89M$ -7.83M$ -4.57M$ -1.86M
Net Income
$ -15.79M$ -8.89M$ -7.83M$ -4.57M$ -1.86M
Per Share Metrics
Basic EPS
$ -1.21$ -0.69$ -0.61$ -0.35$ -0.15
Diluted EPS
$ -1.21$ -0.69$ -0.61$ -0.35$ -0.15
Weighted Average Shares Outstanding
 13.01M 12.85M 12.91M 12.94M 12.70M
Weighted Average Shares Outstanding (Diluted)
 13.01M 12.85M 12.91M 12.94M 12.70M
Currency in USD

Greenwich LifeSciences Earnings and Revenue History